| Primary |
|
| Grand Mal Convulsion |
100.0% |
|
| Secondary |
| Product Used For Unknown Indication |
44.2% |
| Anaesthesia |
13.0% |
| Maternal Exposure Before Pregnancy |
8.9% |
| Pain |
4.6% |
| Epidural Anaesthesia |
4.1% |
| General Anaesthesia |
3.9% |
| Prophylaxis |
3.0% |
| Foetal Exposure During Pregnancy |
2.5% |
| Anaesthesia Procedure |
2.4% |
| Premedication |
2.3% |
| Drug Use For Unknown Indication |
2.2% |
| Postoperative Analgesia |
1.4% |
| Analgesic Effect |
1.1% |
| Breast Operation |
1.1% |
| Induction Of Anaesthesia |
1.0% |
| Surgery |
1.0% |
| Nerve Block |
0.9% |
| Antibiotic Prophylaxis |
0.8% |
| Scoliosis Surgery |
0.8% |
| Anaesthetic Premedication |
0.7% |
|
| Toxic Epidermal Necrolysis |
13.6% |
| Hepatocellular Injury |
8.6% |
| Pierre Robin Syndrome |
8.6% |
| Shock |
7.4% |
| Urticaria |
6.2% |
| Maternal Exposure Before Pregnancy |
4.9% |
| Paraplegia |
4.9% |
| Respiratory Disorder |
4.9% |
| Tachycardia |
4.9% |
| Victim Of Child Abuse |
4.9% |
| Acute Generalised Exanthematous Pustulosis |
3.7% |
| Altered State Of Consciousness |
3.7% |
| Extrapyramidal Disorder |
3.7% |
| Nausea |
3.7% |
| Ventricular Tachycardia |
3.7% |
| Generalised Erythema |
2.5% |
| Muscle Contracture |
2.5% |
| Myocardial Stunning |
2.5% |
| Overdose |
2.5% |
| Post Procedural Complication |
2.5% |
|
| Concomitant |
| General Anaesthesia |
18.1% |
| Analgesic Therapy |
12.6% |
| Postoperative Analgesia |
8.8% |
| Product Used For Unknown Indication |
7.9% |
| Induction Of Anaesthesia |
5.1% |
| Surgery |
5.1% |
| Drug Use For Unknown Indication |
4.7% |
| Epidural Anaesthesia |
4.2% |
| Colostomy |
3.7% |
| Salpingitis |
3.7% |
| Hypertension |
3.3% |
| Prophylaxis Of Nausea And Vomiting |
3.3% |
| Bacterial Infection |
2.8% |
| Infection Prophylaxis |
2.8% |
| Nephroureterectomy |
2.8% |
| Sedation |
2.8% |
| Antiemetic Supportive Care |
2.3% |
| Vomiting |
2.3% |
| Blood Pressure Management |
1.9% |
| Nausea |
1.9% |
|
| Post Procedural Haemorrhage |
12.5% |
| Monoplegia |
10.0% |
| Tongue Oedema |
10.0% |
| Toxic Skin Eruption |
7.5% |
| Anaphylactic Shock |
5.0% |
| Angioedema |
5.0% |
| Eyelid Oedema |
5.0% |
| Muscular Weakness |
5.0% |
| Ocular Dysmetria |
5.0% |
| Sensory Disturbance |
5.0% |
| Tremor |
5.0% |
| Vascular Purpura |
5.0% |
| Aspartate Aminotransferase Increased |
2.5% |
| Cholestasis |
2.5% |
| Delayed Recovery From Anaesthesia |
2.5% |
| Diplegia |
2.5% |
| Drug Interaction |
2.5% |
| Feeling Abnormal |
2.5% |
| Hypoaesthesia |
2.5% |
| Intentional Drug Misuse |
2.5% |
|
